Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds President Biden Expected To Speak Within Next Hour – CNBC

News

President Biden Expected To Speak Within Next Hour – CNBC

– CNBC

byBenzinga Newsdesk

September 8, 2022

1 minute read

– CNBC

News

CollPlant, Tel Aviv University And Sheba Medical Center Join Forces To Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model For Drug Discovery And Personalized Treatment Of Ulcerative Colitis

By Benzinga Newsdesk

November 15, 8:14 AM

Agreement to accelerate development of a 'Gut-on-a-Chip' tissue model to improve therapeutic choice and outcome of ulcerative colitis patients CollPlant to fund development and receive exclusive

CLGN

What’s Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday?

By Vandana Singh

February 20, 1:30 PM

Chemomab Therapeutics' CM-101 granted new patents in Brazil and Israel, currently in Phase 2 SPRING trial for primary sclerosing cholangitis. Topline data readout expected by mid-2024.

CMMB

Citigroup Upgrades Rigel Pharmaceuticals to Buy

By Benzinga Newsdesk

December 2, 3:35 PM

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

RIGL

Apple Loses Appeal Over 4G Patent Infringement in London Court, Optis Scores Another Victory

By Anusuya Lahiri

July 5, 8:05 AM

Apple Inc (NASDAQ: AAPL) overstepped two telecommunications patents used in devices, including iPhones and iPads, London's Court of Appeal ruled on Tuesday, dismissing the iPhonemaker's appeal in a

AAPL

President Biden Expected To Speak Within Next Hour – CNBC

Related Posts

CollPlant, Tel Aviv University And Sheba Medical Center Join Forces To Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model For Drug Discovery And Personalized Treatment Of Ulcerative Colitis

What’s Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday?

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Apple Loses Appeal Over 4G Patent Infringement in London Court, Optis Scores Another Victory